Spanish Regulatory Medicine Agency allows Digna Biotech, Biotecnol to initiate Cardiotrophin I trial
The clinical trial will be conducted in Hospital Universitario Puerta de Hierro de Majadahonda in Madrid and Clinica Universidad de Navarra in Pamplona. According to researchers at the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.